MPP Strikes Deal For Long-Acting Injectable HIV Candidate

Monthly Subcutaneous Injection Licensed From University Of Washington Could Replace Daily Pills

The University of Washington has agreed to license an in-development HIV treatment to the Medicines Patent Pool, which takes the form of a monthly subcutaneous injection instead of daily oral treatment.

HIV ribbon
MPP has added another HIV candidate to its portfolio • Source: Alamy

More from Generics

More from Products